Elaine Xu

Since joining Kirkland & Ellis, Elaine has represented the following:

• Certain affiliates of Bain Capital on the US$3.16 billion take-private of Chindata Group Holdings Limited (NASDAQ: CD), a leading carrier-neutral hyperscale data center solution provider in Asia-Pacific emerging markets. This transaction was named “Best Private Equity Deal - China Offshore” by FinanceAsia Achievement Awards 2023, “Deals of the Year 2023” by China Business Law Journal and “Private Equity Deal of the Year” by IFLR Asia-Pacific Awards 2024
• Crescent Point Capital on the acquisition by Ares Management Corporation of the Crescent Point Capital platform, a leading Asia-focused private equity platform
• Asia Innovations Group Limited (ASIG), a leading mobile social company across emerging markets, on its proposed business combination with Magnum Opus Acquisition Limited (NYSE: OPA), a special purpose acquisition company. The business combination, which provides for an equity valuation of $2.5 billion for the combined company. This transaction was named “Deals of the Year 2022” by China Business Law Journal
• Bain Capital on its leveraged buy-out of VXI Global Solutions, a leading provider of Business Process Outsourcing services to businesses around the world, from the Carlyle Group
• The Blackstone Group on its acquisition of all of the issued share capital of Interplex Holdings Pte. Ltd., which was indirectly owned by funds managed by Baring Private Equity Asia, in a transaction valued at approximately US$1.6 billion
• A consortium of investors, comprising Centurium Capital, PW Medtech Group Limited (HKSE: 1358), CITIC Capital, Hillhouse Capital, Temasek and Marc Chan, in the take-private of China Biologic Products Holdings, Inc. (NASDAQ: CBPO), a leading fully integrated plasma-based biopharmaceutical company in China, at a valuation of approximately US$4.6 billion. This transaction was named Pharmaceuticals, Medical and Biotech M&A Deal of the Year by Mergermarket China M&A Awards 2021, “2021 Deals of the Year” by China Business Law Journal, “M&A Deal of the Year” by China Law & Practice Awards 2021 and “Private Equity Deal of the Year” by IFLR Asia-Pacific Awards 2022
• Bullish, a technology company focused on developing financial services for the digital assets sector, on its definitive agreement to go public on the New York Stock Exchange through a merger with Far Peak Acquisition Corporation (NYSE: FPAC), a special purpose acquisition company, for approximately US$9 billion
• Azentio Software, a Singapore-headquartered software products business owned by funds advised by Apax, on its binding agreement to acquire Beyontec, a leading insurance technology company
• Chindata Group Holdings Limited, a carrier-neutral hyperscale data center solution provider in Asia and a Bain portfolio company, in its US$621 million Nasdaq IPO under the symbol “CD”. Kirkland also represented Chindata in its concurrent private placements for an aggregate amount of US$135 million
• Advised as international co-counsel for an investor consortium, comprising Warburg Pincus Asia LLC, General Atlantic Singapore Fund Pte. Ltd., Ocean Link Partners Limited, and Mr. Jinbo Yao, Chairman of the Board and Chief Executive Officer of 58.com, in the take-private of 58.com Inc. (NYSE: WUBA), China’s largest online classifieds marketplace, at a valuation of approximately US$8.7 billion. This transaction was named Finance Deal of the Year: Acquisitions by The Asia Legal Awards 2021 and “Finance Deal of the Year” by China Law & Practice Awards 2021
• As an international co-counsel and sole debt financing counsel for an investor consortium, comprising DCP Capital Partners II, L.P., Ocean Link Partners Limited, and Mr. Rick Yan, the Chief Executive Officer of 51job, in the take-private of 51job, Inc. (NASDAQ: JOBS) at a valuation of appropriately US$4.3 billion. This transaction was named “2021 Deals of the Year” by China Business Law Journal and “TMT Deal of the Year” by Asia Legal Awards 2022
• Sea Limited (NYSE: SE), a leading global consumer internet company, in the acquisition by its digital entertainment arm, Garena, of Phoenix Labs, an acclaimed independent games development company founded in Vancouver
• An investor consortium led by Mr. Bizuo (Tony) Liu, the Chief Executive Officer of Cellular Biomedicine Group Inc. (NASDAQ: CBMG), certain other senior management members of Cellular Biomedicine, Hillhouse Bio Holdings, L.P. and TF Capital Ranok Ltd. and also including Dangdai International Group Co., Limited and Mission Right Limited in a proposed take private of Cellular Biomedicine, a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases

Prior to joining Kirkland & Ellis, Elaine has represented the following:

• Tongcheng Network Technology Limited, in connection with its combination with China E-dragon Holdings Limited
• J.P. Morgan, Credit Suisse, Goldman Sachs, CICC and China Renaissance as underwriters, in the US$585 million initial public offering and listing on the New York Stock Exchange of Sogou Inc.